On Invalid Date, Merck & Co (NYSE: MRK) reported Q1 2024 earnings per share (EPS) of $1.88, up 69.37% year over year. Total Merck & Co earnings for the quarter were $4.76 billion. In the same quarter last year, Merck & Co's earnings per share (EPS) was $1.11.
As of Q2 2024, Merck & Co's earnings has grown -82.26% year over year. This is 101.88 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 19.62%. Merck & Co's earnings in the past year totalled $2.31 billion.
What is MRK's earnings date?
Merck & Co's earnings date is Invalid Date. Add MRK to your watchlist to be reminded of MRK's next earnings announcement.
What was MRK's revenue last quarter?
On Invalid Date, Merck & Co (NYSE: MRK) reported Q1 2024 revenue of $15.78 billion up 8.89% year over year. In the same quarter last year, Merck & Co's revenue was $14.49 billion.
What was MRK's revenue growth in the past year?
As of Q2 2024, Merck & Co's revenue has grown 6.11% year over year. This is 2.74 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.85%. Merck & Co's revenue in the past year totalled $61.40 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.